ArrowMark Colorado Holdings’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49M | Sell |
358,614
-3,108
| -0.9% | -$56.3K | 0.12% | 172 |
|
|
2025
Q1 | $7.4M | Buy |
361,722
+16,674
| +5% | +$341K | 0.12% | 150 |
|
|
2024
Q4 | $8.87M | Sell |
345,048
-9,927
| -3% | -$255K | 0.12% | 149 |
|
|
2024
Q3 | $5.89M | Buy |
354,975
+57,806
| +19% | +$960K | 0.08% | 175 |
|
|
2024
Q2 | $5.71M | Buy |
297,169
+362
| +0.1% | +$6.95K | 0.07% | 191 |
|
|
2024
Q1 | $7.02M | Buy |
+296,807
| New | +$7.02M | 0.08% | 181 |
|